TwinBeech Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
+137,756
| New | +$1.29M | 0.03% | 381 |
|
|
2024
Q4 | – | Sell |
-175,023
| Closed | -$3.6M | – | 832 |
|
|
2024
Q3 | $3.6M | Buy |
175,023
+75,071
| +75% | +$1.54M | 0.07% | 312 |
|
|
2024
Q2 | $2.24M | Buy |
+99,952
| New | +$2.24M | 0.04% | 319 |
|
|
2024
Q1 | – | Sell |
-17,014
| Closed | -$519K | – | 773 |
|
|
2023
Q4 | $519K | Sell |
17,014
-82,266
| -83% | -$2.51M | 0.01% | 548 |
|
|
2023
Q3 | $3.14M | Buy |
99,280
+61,952
| +166% | +$1.96M | 0.06% | 335 |
|
|
2023
Q2 | $1.52M | Sell |
37,328
-121,951
| -77% | -$4.97M | 0.03% | 412 |
|
|
2023
Q1 | $5.94M | Sell |
159,279
-5,081
| -3% | -$189K | 0.12% | 214 |
|
|
2022
Q4 | $5.73M | Buy |
164,360
+67,890
| +70% | +$2.37M | 0.11% | 226 |
|
|
2022
Q3 | $5.4M | Buy |
+96,470
| New | +$5.4M | 0.14% | 175 |
|